Science News
from research organizations

Next-generation microscopy

'Pharmacoscopy' enables immunomodulatory drug discovery by analyzing immune cell interactions

Date:
April 24, 2017
Source:
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Summary:
A novel microscopy method allows unprecedented insights into the spatial organization and direct interactions of immune cells within blood and liquid multi-lineage tissues. The assay, called 'Pharmacoscopy,' is able to determine the immunomodulatory properties of drugs within large libraries on immune cells in high resolution and high throughput, enabling new possibilities for drug discovery, particularly in cancer immunotherapy, personalized medicine, and research on signaling pathways of the immune system.
Share:
FULL STORY

Gregory Vladimer, Nikolaus Krall, Berend Snijder and Giulio Superti-Furga (from left to right) are next to the Pharmacoscopy high-throughput microscope.
Credit: Wolfgang Däuble/CeMM

Our immune system consists of a great variety of cell types fulfilling diverse tasks in monitoring tissue homeostasis to protect against pathogens and to remove damaged cells. To ensure the smooth and controlled functioning of this highly complex system, a fine-tuned coordination is necessary that requires sophisticated communication. For that purpose, immune cells use a wide range of biochemical signaling pathways, activated by soluble proteins or direct cell-cell contacts. Those pathways are also targeted by modern drugs, for instance cancer immunotherapies, that direct the immune response against specific structures or cell types.

The search for new drugs, small molecule or biologicals, that influence the immune system in a desired manner is challenging: immune signaling, often a combination of communication via soluble proteins and direct interaction by cell-cell contacts, is subtle and hard to track in all its nuances. So far, there has been a lack of fast and robust technology to measure the effect of a potential immunomodulatory drug in particular in a cell-cell contact dimension.

By combining state-of-the-art high-throughput fluorescent microscopy with single cell image analysis and novel analysis algorithms, Pharmacoscopy provides a powerful solution. Developed by a group of scientists at CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences led by Director Giulio Superti-Furga and tested in collaboration with the Medical University of Vienna, Pharmacoscopy can quantify the overall spatial patterning and direct interactions of immune cells within blood with unprecedented speed and accuracy. The method was introduced in Nature Chemical Biology.

Combined single cell resolution and fully automated platform control, Pharmacoscopy can test large drug libraries, as available in Stefan Kubicek's PLACEBO (Platform Austria for Chemical Biology) laboratory, for compounds with immunomodulatory potential. "We found that 10% of all approved drugs tested influence the immune system in some way -- much of which was not known" states Gregory Vladimer, one of the co-first authors of the study.

With this method, the scientists identified Crizotinib, an FDA approved drug for non-small cell lung cancer, to have a previously unknown immunomodulatory potential: "With Pharmacoscopy, we could track how Crizotinib enables cytotoxic T-cells to attack cancer cells" explains Berend Snijder, the other co-first author. "The compound induces the upregulation of MHC on the surface of cancer cells, a protein complex that is recognized by T-cells and leads to their killing."

"This is the world´s first method to track the modulation of the immune system at high-resolution and high-throughput," says Giulio Superti-Furga, senior author of the study and scientific director of CeMM. "Pharmacoscopy is not only a new and powerful tool for drug discovery; it can also be implemented in basic research by visualizing the effects of signaling molecules on the immune system. In future, Pharmacoscopy should be applied to test individual patient samples on their response to various drugs -- a mile stone for the development of a personalized precision medicine."


Story Source:

Materials provided by CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences. Note: Content may be edited for style and length.


Journal Reference:

  1. Berend Snijder et al. Global survey of the immunomodulatory potential of common drugs. Nature Chemical Biology, April 2017 DOI: 10.1038/nchembio.2360

Cite This Page:

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences. "Next-generation microscopy: 'Pharmacoscopy' enables immunomodulatory drug discovery by analyzing immune cell interactions." ScienceDaily. ScienceDaily, 24 April 2017. <www.sciencedaily.com/releases/2017/04/170424141303.htm>.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences. (2017, April 24). Next-generation microscopy: 'Pharmacoscopy' enables immunomodulatory drug discovery by analyzing immune cell interactions. ScienceDaily. Retrieved May 25, 2017 from www.sciencedaily.com/releases/2017/04/170424141303.htm
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences. "Next-generation microscopy: 'Pharmacoscopy' enables immunomodulatory drug discovery by analyzing immune cell interactions." ScienceDaily. www.sciencedaily.com/releases/2017/04/170424141303.htm (accessed May 25, 2017).

RELATED STORIES